Nu Skin Enterprises Files 8-K on Financials

Ticker: NUS · Form: 8-K · Filed: 2025-05-08T00:00:00.000Z

Sentiment: neutral

Topics: financial-reporting, operations

TL;DR

NU SKIN 8-K filed: Financials and operations update.

AI Summary

Nu Skin Enterprises, Inc. filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. The company is incorporated in Delaware and headquartered in Provo, Utah.

Why It Matters

This filing provides investors with crucial updates on Nu Skin's financial performance and operational status, impacting investment decisions.

Risk Assessment

Risk Level: low — This is a routine filing reporting on financial condition and operations, not indicating immediate significant risk.

Key Players & Entities

FAQ

What specific financial results are being reported in this 8-K?

The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details of the results are not provided in this excerpt.

When was this 8-K filed?

This 8-K was filed on May 8, 2025.

What is Nu Skin Enterprises, Inc.'s principal executive office address?

The principal executive offices are located at 75 West Center Street, Provo, Utah 84601.

What is the company's fiscal year end?

The company's fiscal year ends on December 31.

What is the SIC code for Nu Skin Enterprises, Inc.?

The Standard Industrial Classification (SIC) code is 5122 for Wholesale - Drugs, Proprietaries & Druggists' Sundries.

From the Filing

0001140361-25-017961.txt : 20250508 0001140361-25-017961.hdr.sgml : 20250508 20250508161605 ACCESSION NUMBER: 0001140361-25-017961 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250508 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250508 DATE AS OF CHANGE: 20250508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NU SKIN ENTERPRISES, INC. CENTRAL INDEX KEY: 0001021561 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] ORGANIZATION NAME: 07 Trade & Services EIN: 870565309 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12421 FILM NUMBER: 25926362 BUSINESS ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 BUSINESS PHONE: 801-345-1000 MAIL ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ENTERPRISES INC DATE OF NAME CHANGE: 19980909 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ASIA PACIFIC INC DATE OF NAME CHANGE: 19960919 8-K 1 ef20048613_8k.htm FORM 8-K false 0001021561 0001021561 2025-05-08 2025-05-08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   May 8, 2025     Date of Report (Date of earliest event reported)           NU SKIN ENTERPRISES, INC.     (Exact name of registrant as specified in its charter)   Delaware   001-12421   87-0565309 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification Number)   75 West Center Street Provo , Utah 84601     (Address of principal executive offices and zip code)           ( 801 ) 345-1000     (Registrant’s telephone number, including area code)           N/A     (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class Trading Symbol(s) Name of each exchange on which registered Class A Common Stock, $.001 par value NUS New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 2.02 Results of Operations and Financial Condition. On May 8, 2025, Nu Skin Enterprises, Inc. (the “Company”) issued a press release announcing its financial results for the three-month period ended March 31, 2025, and certain other information. A copy of the press release is attached as Exhibit 99.1 to this report. The information furnished pursuant to this Item 2.02 and

View on Read The Filing